Analysis of physicochemical properties for drugs from nature

Medicinal Chemistry Research

Volumn 19, Issue 8, 2010, Pages 984-992

  Prashantha Kumar, B R ^a   Soni, Mukesh ^a   Bharvi Bhikhalal, U ^a   Kakkot, Ismayil R ^a   Jagadeesh, Meghana ^a   Bommu, Praveen ^a   Nanjan, M J ^a  

^a JSS COLLEGE OF PHARMACY   (India)

Author keywords

Druggability; Lipinski's rule of five; Natural products; Physicochemical parameters; Semisynthetic natural products; Synthetic natural products

Indexed keywords

NATURAL PRODUCT;

ARTICLE; CALCULATION; CHEMICAL BOND; CONFORMATIONAL TRANSITION; DRUG STRUCTURE; HYDROGEN BOND; HYPOTHESIS; MOLECULAR WEIGHT; PARAMETER; PHYSICAL CHEMISTRY; STATISTICAL ANALYSIS; STRUCTURE ANALYSIS; TOPOLOGICAL POLAR SURFACE AREA;

EID: 78650731904     PISSN: 10542523     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00044-009-9244-2     Document Type: Article

References (30)

1. Ajay A, Walters WP, Murko MA (1998) Can we learn to distinguish between drug-like and 'nondrug-like' molecules? J Med Chem 41:3314-3324
2. Babine RE, Bender SL (1997) Molecular recognition of proteinminus signligand complexes: applications to drug design. Chem Rev 97(5):1359-1472
3. Bajorath J (2002) Chemoinformatics methods for systematic comparison of molecules from natural and synthetic sources and design of hybrid libraries. Mol Divers 5(4):305-313
4. Balunas MJ, Kinghorn AD (2005) Drug discovery from medicinal plants. Life Sci 78(5):431-441
5. Bemis GW, MurckoMA(1999) Properties of known drugs. 2. Side chains. J Med Chem 42(25):5095-5099
6. British Pharmacopeia Commission (2005) British pharmacopoeia, vols I-IV. Stationery Office Books, London
7. Clardy J, Walsh C (2004) Lessons from natural molecules. Nature 432(7019):829-837
8. Clark DE, Pickett SD (2000) Computational methods for the prediction of 'drug-likeness'. Drug Discov Today 5(2):49-58
9. Cragg GM, Newman D (2001) Natural product drug discovery in the next millennium. Pharm Biol 39:8-17
10. Deschamps JD, Gautschi JT, Whitman S, Johnson TA, Gassner NC, Crews P, Holman TR (2007) Discovery of platelet-type 12-human lipoxygenase selective inhibitors by high-throughput screening of structurally diverse libraries. Bioorg Med Chem 15(22):6900-6908
11. Ertl P, Rohde B, Selzer P (2000) Fast calculation of molecular polar surface area as a sum of fragmentbased contributions and its application to the prediction of drug transport properties. J Med Chem 43(20):3714-3717
12. Faller B, Ertl P (2007) Computational approaches to determine drug solubility. Adv Drug Deliv Rev 59(7):533-545
13. Ganesan A (2008) The impact of natural products upon modern drug discovery. Curr Opin Chem Biol 12(3):306-317
14. Gurib-Fakim A (2006) Medicinal plants: traditions of yesterday and drugs of tomorrow. Mol Aspects Med 27(1):1-93
15. Kola I, Landis J (2004) Can the pharmaceutical industry reduce attrition rates? Nature Rev Drug Discov 3(8):711-715
16. Larsson J, Gottfries J, Bohlin L, Backlund A (2005) Expanding the ChemGPS chemical space with natural products. J Nat Prod 68(7):985-991
17. Lipinski CA (2000) Drug-like properties and the causes of poor solubility and poor permeability. J Pharmacol Toxicol Methods 44(1):235-249
18. Lipinski CA (2004) Lead- and drug-like compounds: the rule-of-five revolution. Drug Discov Today Technol 1(4):337-341
19. Lipinski CA, Lombardo F, Dominy BW, Feeney PJ (1997) Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev 23:3-25
20. Molinspiration Cheminformatics. Nova ulica 61, SK-900 26. Available at: http://www.molinspiration.com/ cgi-bin/properties
21. Merck (2001) Merck index, chemicals, drugs and biological, 13th edn. Merck, White House Station
22. Muegge I, Heald SL, Britelli D (2001) Simple selection criteria for drug-like chemical matter. J Med Chem 44(12):1841-1846
23. Newman DJ, Cragg GM, Sander KM (2003) Natural products as sources of new drugs over the period 1981-2002. J Nat Prod 66:1022-1037
24. Proudfoot JR (2002) Drugs, leads, and drug-likeness: an analysis of some recently launched drugs. Bioorg Med Chem Lett 12(12):1647-1650
25. Sadowski J, Kubinyi H (1998) A scoring scheme for discriminating between drugs and nondrugs. J Med Chem 41(18):3325-3329
26. Swarna VM, Undem BJ, Korlipara VL (2007) Design and synthesis of 3,5-disubstituted benzamide analogues of DNK333 as dual NK1/NK2 receptor probes. Bioorg Med Chem Lett 17(4):890-894
27. Tan DS (2005) Diversity-oriented synthesis: exploring the intersections between chemistry and biology. Nat Chem Biol 1(2):74-84
28. Tan NC, Yu P, Kwon YU, Kodadek T (2008) High-throughput evaluation of relative cell permeability between peptoids and peptides. Bioorg Med Chem 16(11):5853-5861
29. U.S. Pharmacopeia (2006) United States pharmacopeia. 29th rev. USP Convention, Rockville
30. Zhang M, WilkinsonB(2007) Drug discovery beyond the rule-of-five. Curr Opin Biotechnol 18(6):478-488